{
  "catalogId": "cd4f51b2-a3fd-4a7f-85c4-b23e2be910fd",
  "name": "ABIRATERONE MEDOMIE 250 MG",
  "status": "draft",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "171 35 37168 99",
  "treatmentDescriptions": "a CYP17 inhibitor indicated:- in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer.- for the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mHSPC) in adult men in combination with androgen deprivation therapy (ADT)",
  "termsOfIssue": "Prescription required",
  "form": "tablets",
  "route": "per os",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "ABIRATERONE ACETATE",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "L02BX03",
      "name": "ABIRATERONE"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "ABIRATERONE MEDOMIE 250 MG 120 TAB",
      "manufacturer": {
        "name": "מדומי פארמה",
        "countryOfOrigin": "IL"
      },
      "strength": {
        "value": 0,
        "unit": ""
      },
      "quantity": {
        "value": 120.0,
        "unit": "units"
      },
      "packagingDescription": "BOTTLE HDPE",
      "shelfLife": "36",
      "storageConditions": "",
      "codes": {
        "moh": "9410",
        "yarpa": "16192"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 13221.014,
        "retailMargin": 10.0,
        "maxRetailPrice": 14543.1154,
        "maxPriceWithVAT": 17160.87617
      }
    }
  ],
  "metadata": {
    "version": "1.4",
    "lastUpdated": "2025-07-31T22:09:13.516314"
  }
}